entertainment -WSS

entertainment

author：explore 2025-09-30 17:03:45 - browse：69

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

“I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Colorectal cancer study finds potential in overlooked immune cell

WSS

The tragedy of Johnson & Johnson’s Covid vaccine

Francis Collins on trust in science and how Covid communications failed

Sana to lay off nearly a third of staff, de

Phenylephrine and the overlooked value of the placebo effect

My yearlong odyssey to get my son’s ADHD medication covered

Physician executives need more than on

focus

entertainment

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

My yearlong odyssey to get my son’s ADHD medication covered

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Continuity nursing helped my family in our darkest PICU moments

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

The high cost of giving birth even with insurance

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Activists slam private health insurers over coverage restrictions

Why age limits for politicians are a terrible idea

focus

My yearlong odyssey to get my son’s ADHD medication covered

The tragedy of Johnson & Johnson’s Covid vaccine

NIH director takes cautious approach to Biden drug pricing priority

A virus, fished out of a lake, may have saved a man’s life

AI generated plenty of interest at JPM but not a lot of trust

FDA clears AI tool for detecting skin cancer

knowledge

focus

knowledge

hotspot